Skip directly to content

TB R&D Report

TAG's annual Report on Tuberculosis Research Funding Trends tracks how much public, private, philanthropic, and multilateral institutions spend on TB research and development (R&D) across six areas of research: basic science, diagnostics, drugs vaccines, operational research, and infrastructure/unspecified projects. The report measures how investment totals in these research categories compare with the funding targets outlined in the Stop TB Partnership’s Global Plan to Stop TB. Published every year since 2006, the report serves as the leading reference document on TB R&D investments among researchers, activists, civil-society organizations, and policy markers working to end TB.

If you are a funder of TB R&D and would like your institution to be included in future reports, please contact tbrdtracking@treatmentactiongroup.org.

Past reports in this series can be found here: